tert-Butyl 3-(3-fluoro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)piperidine-1-carboxylate

Catalog No. :
ACBEDI269
CAS No. :
2222996-49-6
Molecular Formula :
C22H33BFNO4
Molecular Weight :
405.32

IUPAC Name:tert-butyl 3-(3-fluoro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)piperidine-1-carboxylate

tert-Butyl 3-(3-fluoro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)piperidine-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$690.00Login to see priceInquiryInquiry
100mg95%$863.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 3-(3-fluoro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)piperidine-1-carboxylate
IUPAC Nametert-butyl 3-(3-fluoro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)piperidine-1-carboxylate
MDL No.MFCD26404963
Molecular FormulaC22H33BFNO4
Molecular Weight405.32
SMILESFC1=CC(C2CN(C(OC(C)(C)C)=O)CCC2)=CC(B(O3)OC(C)(C)C3(C)C)=C1
InChI KeyDATMQFIUSKLXRQ-UHFFFAOYSA-N
Synonym3-(N-Boc-Piperidin-3-yl)-5-fluorophenylboronic acid pinacol ester;1-Piperidinecarboxylic acid, 3-[3-fluoro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-, 1,1-dimethylethyl ester;3-(1-Boc-3-piperidyl)-5-fluorophenylboronic Acid Pinacol Ester
CAS No.2222996-49-6

Synthetic Route by SureRoute

1. ACBEDI269 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  4. Then
  5. ACBEDI269 route product structure diagram
    ACBEDI2692222996-49-6
Inquiry

2. ACBEDI269 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACBEDI269 route product structure diagram
    ACBEDI2692222996-49-6
Inquiry

Comments (0)